Assessment of lupus: where are we now?
Decisions about treatment for patients with SLE are based on numerous criteria, including the rate of change of clinical features and disease markers (especially antibodies to dsDNA and markers of complement turnover), which organ systems are affected, the severity of manifestations, and the presenc...
Sábháilte in:
| Foilsithe in: | Ann Rheum Dis |
|---|---|
| Príomhchruthaitheoirí: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMJ Publishing Group
1993
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8484667/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.3.169 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|